SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 193 filers reported holding SAGE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,010,833 | $10,977,646 | 1.27% |
| RTW INVESTMENTS, LP | 5,480,577 | $59,519,066 | 0.92% |
| Bellevue Group AG | 4,464,693 | $48,486,566 | 0.79% |
| 683 Capital Management, LLC | 500,000 | $5,430,000 | 0.41% |
| DAFNA Capital Management LLC | 116,200 | $1,261,932 | 0.30% |
| PDT Partners, LLC | 233,642 | $2,537,352 | 0.24% |
| Values First Advisors, Inc. | 28,962 | $314,528 | 0.19% |
| Corton Capital Inc. | 26,841 | $291,493 | 0.15% |
| Virtus ETF Advisers LLC | 28,639 | $311,020 | 0.15% |
| Granahan Investment Management | 347,529 | $3,774,165 | 0.15% |
| EASTERLY INVESTMENT PARTNERS LLC | 136,602 | $1,483,498 | 0.13% |
| BOOTHBAY FUND MANAGEMENT, LLC | 473,500 | $5,142,210 | 0.12% |
| FOX RUN MANAGEMENT, L.L.C. | 40,747 | $442,512 | 0.08% |
| COWEN AND COMPANY, LLC | 214,232 | $2,326,559 | 0.06% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,425,378 | $15,479,605 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 78,749 | $855 | 0.06% |
| Trexquant Investment LP | 315,243 | $3,423,539 | 0.05% |
| Pennant Investors, LP | 17,500 | $190,050 | 0.05% |
| PINNACLE ASSOCIATES LTD | 293,251 | $3,184,706 | 0.05% |
| Point72 Asia (Singapore) Pte. Ltd. | 21,806 | $236,813 | 0.05% |
External links
This page lists SAGE THERAPEUTICS INC's shareholders in Q2 2024. To view SAGE THERAPEUTICS INC's shareholder history, click here.